Clinical trial
Shingles Prevention Study
NCT00007501 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00007501 |
|---|---|
| Title | Shingles Prevention Study |
| Official title | CSP #403 - Trial of Varicella Zoster Vaccine for the Prevention of Herpes Zoster and Its Complications |
| Acronym | SPS |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Collaborators | Merck Sharp & Dohme LLC Industry National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Herpes Zoster, Postherpetic Neuralgia |
| Intervention type | Biological |
| Interventions | Varicella-zoster vaccine, Placebo |
| Enrollment | 38,456 |
| Start date | Nov 1, 1998 |
| Primary completion | Apr 1, 2004 |
| Completion | Feb 1, 2011 |
| First posted | Jan 1, 2001 |
| Last update posted | Jul 4, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: